WallStreetZenWallStreetZen

NASDAQ: VIRX
Viracta Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

VIRX past revenue growth

How has VIRX's revenue growth performed historically?
Company
N/A
Industry
154.55%
Market
17.87%
VIRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VIRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

VIRX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$51.1M
Current Profit Margin
0%

VIRX Return on Equity

Current Company
-145.6%
Current Industry
-63.5%
Current Market
188%
VIRX's Return on Equity (-145.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VIRX announces earnings.

VIRX Return on Assets

Current Company
-71.5%
Current Industry
2.9%
VIRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VIRX Return on Capital Employed

Current Company
-258.5%
Current Industry
19.5%
VIRX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VIRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VIRX$0.00-$46.86M-$51.06M-100.00%N/A
NTRB$2.09M-$4.92M-$5.28M+66.58%N/A
SRZN$0.00-$39.86M-$43.04M-100.00%N/A
INKT$0.00-$22.25M-$22.46M-100.00%N/A
ACST$0.00-$48.89M-$38.77M-100.00%N/A
View Top Biotech Stocks

VIRX earnings dates

Next earnings date
May 6, 2024

Viracta Therapeutics Earnings & Revenue FAQ

What were VIRX's earnings last quarter?

On Invalid Date, Viracta Therapeutics (NASDAQ: VIRX) reported Q4 2023 earnings per share (EPS) of -$0.35, up 29.63% year over year. Total Viracta Therapeutics earnings for the quarter were -$13.77 million. In the same quarter last year, Viracta Therapeutics's earnings per share (EPS) was -$0.27.

If you're new to stock investing, here's how to buy Viracta Therapeutics stock.

What was VIRX's earnings growth in the past year?

As of Q2 2024, Viracta Therapeutics's earnings has grown year over year. Viracta Therapeutics's earnings in the past year totalled -$51.06 million.

What is VIRX's earnings date?

Viracta Therapeutics's earnings date is Invalid Date. Add VIRX to your watchlist to be reminded of VIRX's next earnings announcement.

What was VIRX's revenue last quarter?

On Invalid Date, Viracta Therapeutics (NASDAQ: VIRX) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Viracta Therapeutics's revenue was $0.00.

What was VIRX's revenue growth in the past year?

As of Q2 2024, Viracta Therapeutics's revenue has grown null year over year. Viracta Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.